Home6K9 • FRA
add
Context Therapeutics Inc
Previous close
€2.02
Day range
€2.00 - €2.00
Year range
€0.44 - €2.14
Market cap
211.32M USD
Avg Volume
520.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.61M | -43.26% |
Net income | -9.69M | 44.48% |
Net profit margin | — | — |
Earnings per share | -0.10 | 54.55% |
EBITDA | -10.61M | 43.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.94M | -9.27% |
Total assets | 79.23M | -8.22% |
Total liabilities | 6.06M | 145.00% |
Total equity | 73.17M | — |
Shares outstanding | 91.88M | — |
Price to book | 2.52 | — |
Return on assets | -31.89% | — |
Return on capital | -34.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.69M | 44.48% |
Cash from operations | -6.58M | -240.29% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -6.58M | 60.69% |
Free cash flow | -3.52M | 86.32% |
About
Founded
2015
Headquarters
Website
Employees
12
